2019
DOI: 10.1016/j.neurol.2018.04.010
|View full text |Cite
|
Sign up to set email alerts
|

New findings in facial-onset sensory and motor neuronopathy (FOSMN) syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
29
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(32 citation statements)
references
References 32 publications
2
29
0
Order By: Relevance
“…Thus, we think that taste disorder in our patient was associated with FOSMN. Approximately 50 patients with FOSMN have been described in the literature to date [10,11,18], with 8 of them showing taste disturbance (Table 1). Most patients with taste disorder developed taste disturbance during the course of the disease.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, we think that taste disorder in our patient was associated with FOSMN. Approximately 50 patients with FOSMN have been described in the literature to date [10,11,18], with 8 of them showing taste disturbance (Table 1). Most patients with taste disorder developed taste disturbance during the course of the disease.…”
Section: Discussionmentioning
confidence: 99%
“…Our literature search yielded 26 full-text articles reporting on a total of 64 patients with FOSMN, of which 29 were not described in a review before. 1,[3][4][5][6][7][8][9][10][11][12][13][14][15][16][18][19][20][21][22][23][24] We further identified 7 abstracts/posters/ supplements reporting on 11 potential cases and 2 articles mentioning 10 FOSMN cases without further patient characteristics. 25,26 After reaching out to the corresponding authors, we received a detailed poster on 7 patients with FOSMN.…”
Section: Updated Case Series and Clinical Findingsmentioning
confidence: 99%
“…Upper motor neuron signs, such as brisk reflexes, Babinski sign, and clonus, were reported in 27 cases. [3][4][5][6][7][8][9][10][11]14 Natural history The mean age at onset is approximately 55 years (range 7-78 years). The rate of progression is highly variable, and survival ranges from 14 months to over 46 years.…”
Section: Updated Case Series and Clinical Findingsmentioning
confidence: 99%
See 2 more Smart Citations